Macrophage Activity Test of Pulmonary Tuberculosis Patients with Diabetes Mellitus (TB-DM)

*Arlita Leniseptaria Antari orcid  -  Faculty of Medicine Diponegoro University, Indonesia
Indah Saraswati  -  Faculty of Medicine Diponegoro University, Indonesia
David Pakaya  -  Faculty of Medicine and Health Science Tadulako University, Indonesia
Aryoko Widodo  -  Faculty of Medicine Diponegoro University, Indonesia
Received: 1 Dec 2016; Published: 29 Dec 2016.
Open Access
Citation Format:
Article Info
Section: Original Research Articles
Language: EN
Full Text:
Supp. File(s):
Macrophages of TB-DM patients ingested M. tuberculosis (NIKON Eclipse E600 light microscope, magnification of 1700X)
Type Research Results
  Download (69KB)    Indexing metadata
Average of TNF-α levels secreted by macrophages of TB-DM patients, TB patients non-DM, and healthy individuals
Type Research Results
  Download (15KB)    Indexing metadata
Average number of viable M. tuberculosis colonies (CFU / ml)
Type Research Results
  Download (15KB)    Indexing metadata
TNF-α levels secreted by macrophages of TB-DM patients, TB patients non-DM, and healthy individuals
Type Research Results
  Download (15KB)    Indexing metadata
Statistics: 421 188


Background: Control of pulmonary TB is getting more and more complicated as the number of patients with diabetes mellitus (DM) is increasing. The increasing prevalence of DM is followed by the increasing prevalence of pulmonary TB. Diabetes Mellitus patients have 4,7 times higher risk to develop pulmonary TB compared to patients without DM, since DM can increase the frequency and severity of an infection, including pulmonary TB.

Aim: To analyze macrophage activity (phagocytosis, intracellular killing, and TNF-α synthesis) of TB-DM patients.

Method: The research is an experimental study using a PBMC cultured sample from TB-DM patient's which undergo observation of macrophage activity (phagocytic, intracellular killing and TNF-α synthesis). The data were taken from microscopic observation of TB-DM patients, colony growth of viable Mycobacterium tuberculosis and the TNF-α level secreted by macrophages.

Result: Microscopic observation showed that there are less amount of phagocytosed M. tuberculosis (in macrophage/intracellular level) and there is a little amount of formed vacuoles and giant cells. Furthermore, macrophages in TB-DM patients secrete low level of TNF- α, and there are more viable M. tuberculosis from this macrophage.

Conclusions: Macrophages of TB-DM patients are less activated, with reduced phagocytic activity (due to the intrinsic defect of PMN) and reduced antigen presenting activity of phagocytes toward M. tuberculosis. Therefore, there is a need for a further study focused on macrophage activity enhancement on TB-DM patients against M. tuberculosis infection in DM patients.

Keywords: macrophage, TB-DM, phagocytosis, intracellular killing, TNF- α.


Note: This article has supplementary file(s).

macrophage; TB-DM; phagocytosis; intracellular killing; TNF- α

Article Metrics:

  1. International Diabetes Federation. Diabetes and tuberculosis. 2013.
  2. World Health Organization. 2010. Global tuberculosis control. Geneva: World HealthOrganization.
  3. Perhimpunan Dokter Paru Indonesia (PDPI). 2011. Tuberkulosis: Pedoman diagnosisdan penatalaksanaan di Indonesia. Jakarta: Indah Offset Citra Grafika.
  4. Wang C., Yu X., Cao Q., Wang Y., Zheng G., Tan T.K., ZhaoH., Zhao Y., Wang Y., Harris D.C.H. 2013. Characterization of murine macrophages from bone marrow, spleen and peritoneum. BMC Immunol. 14:6.
  5. Italiani P., Boraschi D. 2014. From monocytes to M1/M2 Macrophages: Phenotypicalvs. functional differentiation. Front Immunol. 17(5):514.
  6. Wang W., Wang J., Dong S.F., Liu C.H., Italiani P., Sun, S.H., Xu J., Boraschi D., Ma S., Qu D. 2010. Immunomodulatory activity of andrographolide on macrophage activation and specific antibody response. Acta Pharmacol Sin.31(2):191-201.
  7. Vega V.L., Charles W., Alexander L. E. C. 2011. Rescuing of deficient killing and phagocytic activities of macrophages derived from non-obese diabetic mice by treatment with geldanamycin or heat shock: potential clinical implications. Cell stresschaperones 16(5):573-81.
  8. Espinoza-JimenezA., Peon A.N., Terrazas, L.I. 2012. Alternatively activated macrophages in types 1 and 2 diabetes. Mediators inflamm.815953.
  9. Parsa R., Andresen P., Gillett A., Mia S., Zhang X.M., Mayans S., Holmberg D., Harris R. 2012. Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice. Diabetes 61(11):2881-92.
  10. Widjajati Laely. 2012. Manfaat dan khasiat bunga sepatu.
  11. Debasish M., Bhattacharyya A., and Basu J., 2011. Lipoarabinomannan from Mycobacterium tuberculosis Promotes Macrophage Survival by Phosphorylating Bad through a Phosphatidylinositol 3-Kinase/Akt Pathway. Department of Chemistry, Bose Institute, Acharya Prafulla Chandra Road, Calcutta, India.